Teva Pharmaceutical Industries (NYSE:TEVA)

Big Pharma Scares Off Short Sellers

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Big Pharma Scares Off Short Sellers

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Unbelievable Swings in Big Pharma Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Bunge, Carbonite, FedEx, Kinder Morgan, Micron, Monster Beverage, Teva, Western Digital and More

Stocks were indicated to open marginally lower on Thursday morning, and the market has felt a bit directionless of late while it awaits a trade deal with China. Investors need ...
Read Full Story »

Major Pharma Sees a Few Wild Swings in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

Stocks were indicated to open marginally higher on Wednesday ahead of the FOMC decision on interest rates. With the market having recouped so much ground in 2019, investors need to ...
Read Full Story »

Big Pharma Short Interest Backs Off, With One Huge Exception

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Flop City: 7 Big Stocks Completely Overlooked by the 10-Year Bull Market

The current bull market is now officially 10 years old. That anniversary took place on Saturday, March 9. The Great Recession was the worst modern-era recession, and it was followed ...
Read Full Story »

Top Analyst Upgrades and Downgrades: CSX, Intelsat, Kohl’s, NIO, Rio Tinto, TripAdvisor, VMware and More

Stocks were indicated to open marginally lower on Wednesday after Tuesday's sell-off. After the Dow Jones industrials had initially risen well over 3,000 points from its lows in January, investors ...
Read Full Story »

Major Pharma Sees Tremendous Rise in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: CenturyLink, Chimera, Comerica, Dish, Exxon, NetApp, Pulte, Petrobras, Teva, Yelp and More

Stocks were indicated to open marginally higher again on Thursday, but the Dow Jones industrial average is now up over 2,700 points from its lows seen at the start of ...
Read Full Story »

What Held Back Teva in Q4

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) released its fourth-quarter financial results before the markets opened on Wednesday. The pharma giant said that it had $0.53 in earnings per share (EPS) ...
Read Full Story »

Major Pharma Scares Off Short Sellers

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Nvidia, Cisco, Under Armour and More Major Earnings Coming This Week

The broad markets ended the past week on a negative note, after coming off of an incredible rally in January. Although many companies ended the week with solid gains from ...
Read Full Story »

Short Interest Spikes in a Couple Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »